PHGE
INDUSTRIALSBiomx Inc
AI Insight
What's Moving PHGE Today?
No stock-specific AI insight has been generated for PHGE yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.36$13.70
$0.46
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-23.30
Dividend Yield—
Dividend / Share—
ROE-403.8%
Profit Margin—
Debt / Equity—
Trading
Volume375K
Avg Volume (10D)—
Shares Outstanding11.8M
PHGE News
22 articles- BiomX Provides Update on Defense Technology Portfolio and Growth StrategyYahoo Finance·Jun 18, 2026
- BiomX Announces NYSE American Acceptance of Plan to Regain ComplianceYahoo Finance·Jun 12, 2026
- BiomX: Zorronet’s AI Security Experts Provide In-Depth Review on Why Security AI Must Move Beyond Detection to Understanding in High-Stakes Global EventsYahoo Finance·Jun 11, 2026
- Another Prominent Defense Technology Leader Joins BiomX: Prof. Gabby Sarusi, Former VP and Chief Scientist at ElbitYahoo Finance·Jun 2, 2026
- Zorronet Brings Autonomous C5ISR to Hardened Sites Without Public Cloud DependenceYahoo Finance·Jun 1, 2026
- BiomX Appoints IDF Colonel (res.) Roy Timor-Rousso as Chief Business Officer to Strengthen Defense & Security OperationsYahoo Finance·May 27, 2026
- BiomX Inc. 1Q 2026: Net income $(19.14M), EPS $(7.38) — 10-Q SummaryTradingView·May 20, 2026
- PHGE: Q1 2026 net loss was $19.1M amid a strategic pivot to defense and security techTradingView·May 20, 2026
- BiomX’s Zorronet Puts Full AI Command-and-Control in the Palm of Your HandYahoo Finance·May 6, 2026
- Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection SystemsYahoo Finance·Apr 16, 2026
- BiomX Accelerates Defense Technology Buildout with DFSL AcquisitionYahoo Finance·Apr 13, 2026
- BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security ApplicationsBenzinga·Apr 10, 2026
- BiomX Obtains Option to Acquire Control of Israeli Laser-Radar Counter-Drone SystemBenzinga·Mar 31, 2026
- BiomX Adds Former Mossad Deputy to Advisory BoardYahoo Finance·Mar 30, 2026
- BiomX Inc. Received NYSE American Notification Letter Regarding Stockholders' Equity DeficiencyYahoo Finance·Mar 27, 2026
- BiomX Launches Security Subsidiary in Israel and Will Initially Invest Over $3 million In Its OperationsYahoo Finance·Mar 26, 2026
- BiomX CEO Issues Letter to StockholdersYahoo Finance·Mar 19, 2026
- BiomX Names Michael Oster as Chief Executive Officer, David Rokach Chief Financial Officer to Support Next Phase of GrowthYahoo Finance·Mar 9, 2026
- BiomX Issues Statement Regarding Recent Common Stock Trading ActivityYahoo Finance·Jan 27, 2026
- BiomX announces $3M private placementYahoo Finance·Dec 30, 2025
- All You Need to Know About BiomX (PHGE) Rating Upgrade to BuyYahoo Finance·Dec 29, 2025
- BiomX Announces $3.0 Million Private PlacementYahoo Finance·Dec 29, 2025
All 22 articles loaded
Price Data
Open$0.43
Previous Close$0.45
Day High$0.50
Day Low$0.43
52 Week High$13.70
52 Week Low$0.36
52-Week Range
$0.36$13.70
$0.46
Fundamentals
Market Cap$5M
P/E Ratio—
EPS$-23.30
Dividend Yield—
Dividend / Share—
ROE-403.8%
Profit Margin—
Debt / Equity—
Trading
Volume375K
Avg Volume (10D)—
Shares Outstanding11.8M
About Biomx Inc
BiomX Inc., a clinical-stage microbiome company, develops products using natural and man-made phage technologies designed to target and kill specific harmful bacteria. The company is headquartered in Ness Ziona, Israel.
INDUSTRIALSAEROSPACE & DEFENSE
Company Details
Security TypeCommon Stock
ExchangeAMEX
CurrencyUSD
Round Lot—
SICAEROSPACE & DEFENSE
CIK—
Composite FIGI—
Share Class FIGI—